Insulin Dependent Diabetes Mellitus Hypothesis of Autoimmunity

References

• National Diabetes Data Group. Classification and diagnosis of diabetes mellitus and other‐ categories of glucose intoler ance. Diabetes. 1979; 28: 1039–1057
   PubMed Web of Science ®Google Scholar
• Bach J F. Mechanisms of autoimmunity in insulin‐dependent diabetes mellitus. Clin Exp Immunol. 1988; 72: 1–8
   PubMed Web of Science ®Google Scholar
• Hitchcock C L, Riley W J, Maclaren N K. Autoimmunity in insulin‐dependent diabetes mellitus: its detection and prevention. Concepts Immunopathol. 1988; 5: 144–167
   PubMedGoogle Scholar
• Cohen I R. Insulin‐dependent diabetes mellitus. Curr Opinion Immunol. 1989; 1: 727–732
   PubMedGoogle Scholar
• Gepts W. Pathology and anatomy of the pancreas in juvenile diabetes mellitus. Diabetes. 1965; 14: 619–633
   PubMed Web of Science ®Google Scholar
• Bottazzo G F, Dean B M, McNally J M, MacKay E H, Swift P G F, Gamble D R. In situ characterization of autoimmune phenomena and expression of HLA molecules in the pancreas in diabetic insulitis. N Engl J Med. 1985; 313: 353–360
   PubMed Web of Science ®Google Scholar
• Sibley R K, Sutherland D E, Goetz F, Michael A F. Recurrent diabetes mellitus in the pancreas iso‐ and allograft. A light and electron microscopic and immunohistochemical analysis of four cases. Lab Invest. 1985; 53: 132–144
   PubMed Web of Science ®Google Scholar
• Pozzilli P, Zuccarini O, Iavicoli M, Andreani D, Sensi M, Spencer K M, et al. Monoclonal antibodies defined abnormalities of T‐lymphocytes in type 1 (Insulin‐dependent) diabetes. Diabetes. 1983; 32: 91–94
   PubMedGoogle Scholar
• Lederman M M, Ellner J J, Rodman H M. Defective suppressor cell generation in juvenile onset diabetes. J lmmunol. 1981; 127: 2051–2055
   PubMedGoogle Scholar
• Quiniou‐Debrie M C, Debray‐Sachs M, Dardenne M, Czernichow P, Assan R, Bach J F. Anti‐islet cellular and humoral immunity, T‐cell subsets, and thymic function in Type 1 diabetes. Diabetes. 1985; 34: 373–379
   PubMed Web of Science ®Google Scholar
• Jackson R A, Morris M A, Haynes B F, Eisenbarth G S. Increased circulating Ia antigen‐bearing T cells in type I diabetes mellitus. N. Engl J Med. 1982; 306: 785–788
   PubMed Web of Science ®Google Scholar
• Lang F, Maugendre D, Houssaint E, Charbonnel B, Sai P. Cytoadherence of lymphocytes from type I diabetic subjects to insulin‐secreting cells. Market of anti‐beta‐cell cellular immunity. Diabeies. 1987; 36: 1356–1364
   PubMedGoogle Scholar
• Topliss D, How J, Lewis M, Row V, Volpe R. Evidence for cell‐mediated immunity and specific suppressor T lymphocyte dysfunction in Graves' disease and diabetes melliltus. J Clin Endocrinol Metab. 1983; 57: 700–705
   PubMed Web of Science ®Google Scholar
• Legendre C M, Schiffrin A, Weitzner G, Colle E, Guttmann R D. Two‐color flow cytometry analysis of activated T‐ lymphocyte subsets in type I diabetes mellitus. Diahetes. 1988; 37: 792–795
   Google Scholar
• Nicoletti F, Meroni P L, Barcellini W, Steinsväg P O, Di Mauro M, Lunetta M, et al. Enhanced percentage of CD5+ B lymphocytes in newly diagnosed IDDM patients. Immunol Lett. 1990; 23: 211–216
   PubMed Web of Science ®Google Scholar
• Huang S ‐W, Maclaren N K. Insulin‐dependent diabetes: a disease of autoaggression. Science 1976; 192: 64–66
   PubMedGoogle Scholar
• Boitard C, Debray Sachs M, Pouplard A, Assan R, Hamburger J. Lymphocytes from diabetics suppress insulin release in vitro. Diabetologia. 1981; 21: 41–46
   PubMed Web of Science ®Google Scholar
• Lohmann D, Krug J, Lampeter E F, Bierwolf B, Verlohren H J. Cell‐mediated immune reactions against B cells and defect of suppressor cell activity in type I (insulin‐dependent) diabetes mellitus. Diabetologia. 1986; 29: 421–425
   PubMed Web of Science ®Google Scholar
• Neel J V. Diabetes mellitus‐A geneticist's nightmare. The genetics of diabetes mellitus, W Creutzfeldt, J Köbberling, J V Neel. Springer‐Verlag, Berlin 1976; 1–11
   Google Scholar
• Tillil H, Köbberling J. Age‐corrected empirical genetic risk estimates for tirst‐degree relatives of IDDM patients. Diabetes. 1987; 36: 93–99
   PubMed Web of Science ®Google Scholar
• Trucco M, Dorman J S. lmmunogenetics of insulin‐dependent diabetes mellitus in humans. CRC Critical Reviews in Immunology. 1989; 9: 201–245
   Google Scholar
• Segall M. HLA and eenetics of IDDM. Holism vs. reductionism. Diabetes. 1988; 37: 1005–1008
   PubMedGoogle Scholar
• Foulis A K, Farquharson M A, Hardman R. Aberrant expression of class II major histocompatibility complex molecules by B cells and hyperexpression of class I major histocompatibility complex molecules by insulin containing islets in type I (insulin‐dependent) diabetes mellitus. Diabetologia. 1987; 30: 333–343
   PubMed Web of Science ®Google Scholar
• Nepom B S, Palmer J, Kim S J, Hansen J A, Holbeck S L, Nepom G T. Specific genomic markers for the HLA‐DQ subregion discriminate between DR4+ insulin‐dependent diabetes mellitus and DR4+ seropositive juvenile rheumatoid arthritis. J Exp Med. 1986; 164: 345–350
   PubMed Web of Science ®Google Scholar
• Todd J A, Bell J I, McDevitt H O. HLA‐DQβ gene contributes to susceptibility and resistance to insulin‐dependent diabetes mellitus. Nature 1987; 329: 599–604
   PubMed Web of Science ®Google Scholar
• Morel P A, Dorman J S, Todd J A, McDevitt H O, Trucco M. Aspartic acid at position 57 of the HLA‐DQ beta chain protects against type 1 diabetes: a family study ‘published erratum appears in. Proc. Natl. Acad. Sci. (USA). 1989; 86: 13171, Proc Natl Acad Sci (USA) 1988, 85, 8111–8115
   Google Scholar
• Yamagata K, Nakajima H, Hanafusa T, Noguchi T, Miyazaki A, Miyagawa J, et al. Aspartic acid at position 57 of DQβ chain does not protect against Type 1 (insulin‐dependent) diabetes mellitus in Japanese subjects. Diabetologia. 1989; 32: 762–764
   PubMed Web of Science ®Google Scholar
• Awata T, Kuzuya T, Matsuda A, Iwamoto Y, Kanazawa Y, Okuyama M, et al. High frequency of aspartic acid at position 57 of HLA‐DQ β‐chain in Japanese IDDM patients and nondiabetic subjects. Diabetes. 1990; 39: 266–269
   PubMed Web of Science ®Google Scholar
• Khail I, D'Auriol L, Gobet M, Morin L, Lepage V, Deschamp I, et al. A combination of HLA‐DQβ Asp57–negative and HLA‐DQα Arg52 confers susceptibility to insulin‐dependent diabetes mellitus. J Clin Invest. 1990; 85: 1315–1319
   PubMedGoogle Scholar
• Rossini A A, Mordes J P, Handler E S. Speculations on etiology of diabetes mellitus: tumbler hypothesis. Diahetes. 1988; 37: 257–261
   Google Scholar
• Hanafusa T, Pujol‐Borrell R, Chiovato L, Russell R C, Doniach D, Bottazzo G F. Aberrant expression of HLA‐DR antigen on thyrocytes in Graves' disease: relevance for autoim munity. Lancet. 1983; 2: 1111–1115
   PubMed Web of Science ®Google Scholar
• Buscema M, Todd I, Deuss U, Hammond L, Mirakian R, Pujol‐Borrell R, et al. Influence of tumor necrosis factor‐alpha on the modulation by interferon‐gamma of HLA class II molecules in human thyroid cells and its effect on interferon‐ gamma binding. J Clin Endocrinol Metab. 1989; 69: 433–439
   PubMed Web of Science ®Google Scholar
• Pujol‐Borrell R, Todd I, Doshi M, Bottazzo G F, Sutton R, Gray D, et al. HLA class II induction in human islet cells by interferon‐gamma plus tumour necrosis Factor or lymphotoxin. Nature 1987; 326: 304–306
   PubMed Web of Science ®Google Scholar
• Walker R, Bone A J, Cooke A, Baird J D. Aberrant expression of class II MHC molecules on pancreatic B‐cells during de velopment of insulin‐dependent diabetes: cause or conse quence?. Frontiers in diabetes research: Lesson from animal diabetes II, E Shafir, A E Renold. John Libbey, London 1988; 185–189
   Google Scholar
• Foulis A K, Farquharson M A. Aberrant expression of HLA‐ DR antigens by insulin‐containing β‐cells in recent‐onset type 1 diabetes mellitus. Diabetes. 1986; 35: 1215–1224
   PubMed Web of Science ®Google Scholar
• Bottazzo G F, Pujol‐Borrell R, Hanafusa T, Feldmann M. Role of aberrant HLA‐DR expression and antigen presentation in induction of endocrine autoimmunity. Lancet. 1983; 2: 1115–1119
   PubMed Web of Science ®Google Scholar
• Pujol‐Borrell R, Todd I. Inappropriate HLA class II in autoimmunity: is it the primary event?. Balliére's Clin Immunol Allergy 1987; 1: 1–27
   Google Scholar
• Bottazzo G F, Foulis A K, Bosi E, Todd I, Pujol‐Borrell R. Pancreatic β‐cell damage. In search of novel pathogenetic factors. Diab Cure. 1988; 11(Suppl. I)24–28
   PubMedGoogle Scholar
• Davies T F, Martin A, Graves P. Human autoimmune thyroid disease: cellular and molecular aspects. Ballière's Clin Endocrinol Metab. 1988; 2: 911–939
   PubMedGoogle Scholar
• Londei M, Lamb J R, Bottazzo G F, Feldmann M. Epithelial cells expressing aberrant MHC class 11 determinants can present antigen to cloned human T cells. Nature 1984; 312: 639–641
   PubMed Web of Science ®Google Scholar
• Londei M, Bottazzo G F, Feldmann M. Human T‐cell clones from autoimmune thyroid glands: specific recognition of autologous thyroid cells. Science 1985; 228: 85–89
   PubMed Web of Science ®Google Scholar
• Bottazzo G F, Florin‐Christensen A F, Donaich D. Islet cell antibodies in diabetes niellitus with autoimmune polyendo‐ crine deficiencies. Lancet. 1974; 2: 1279–1282
   PubMed Web of Science ®Google Scholar
• MacCuish A C, Irvine W J, Baines E W, Duncan L J. Antibodies to pancreatic islet cells in insulin‐dependent diabetics with coexistent autoimmune disease. Lancet. 1974; 2: 1529–1531
   PubMedGoogle Scholar
• Srikanta S, Ganda O P, Jackson R A, Gleason R E, Kaldany A, Garovoy M D, et al. Type I diabetes mellitus in monozygotic twins: Chronic progressive beta cell dysfunction. Ann Intern Med. 1983; 99: 320–326
   PubMed Web of Science ®Google Scholar
• Dobersen M J, Scharff J E, Ginsberg‐Fellner F, Notkins A L. Cytotoxic autoantibodies to beta cells in the serum of patients with insulin‐dependent diabetes mellitus. N Engl J Med. 1980; 303: 1493–1498
   PubMed Web of Science ®Google Scholar
• Baekkeskov S, Nielsen J H, Marner B, Bilde T, Ludvigsson J, Lernmark Å. Autoantibodies in newly diagnosed diabetic children immunoprecipitate human pancreatic islet cell proteins. Nature 1982; 298: 167–169
   PubMed Web of Science ®Google Scholar
• Scherbaum W A, Mogel H, Boehm B O, Hedderich U, Gluck M, Schernthaner G, et al. Autoantibodies to adrenal medullary and thyroid calcitonin cells in type I diabetes mellitus‐a prospective study. J Autoimmun. 1988; 1: 219–230
   PubMed Web of Science ®Google Scholar
• Brown F M, Kamalesh M, Adri M N S, Rabinowe S L. Anti‐adrenal medullary antibodies in IDDM subjects and subjects at high risk of developing IDDM. Diab Care. 1988; 11: 30–33
   PubMed Web of Science ®Google Scholar
• Ziegler A G, Ziegler R, Vardi P, Jackson R A, Soeldner J S, Eisenbarth G S. Life‐table analysis of progression to diabetes of anti‐insulin autoantibody‐positive relatives of individuals with type 1 diabetes. Diabetes. 1989; 38: 1320–1325
   PubMed Web of Science ®Google Scholar
• Nuovo J A, Baker J R, Jr, Wartofsky L, Lukes Y G, Burman K D. Autoantibodies to insulin are present in sera of patients with autoimmune thyroid disease. Diabetes. 1988; 37: 317–320
   PubMed Web of Science ®Google Scholar
• Uchigata Y, Prabhakar B S, Salata K F, Ginsberg‐Fellner F, Notkins A L. Human monoclonal multiple‐organ‐reactive autoantibodies distinguished by mouse monoclonal anti‐ idiotypic antibodies: expression of idiotopes in humans with and without autoimmune diseases. J Immunol. 1987; 138: 4218–4221
   PubMedGoogle Scholar
• Mouradian M, Abourizk N. Diabetes mellitus and thyroid disease. Diab Care. 1983; 6: 512–520
   PubMedGoogle Scholar
• De Baets M H. Autoimmune endocrine diseases. Year Immunol. 1989; 4: 264–275
   PubMedGoogle Scholar
• Rabinowe S L, Eisenbarth G S. Polyglandular autoimmmunity. Adv Intern Mrd. 1986; 31: 293–307
   PubMedGoogle Scholar
• Payami H, Joe S, Thomson G. Autoimmune thyroid disease in type I diabetic families. Genet Epidemiol. 1989; 6: 137–141
   PubMedGoogle Scholar
• Bougneres P F, Carel J C, Castano L, Boitard C, Gardin J P, Landais P, et al. Factors associated with early remission of type 1 diabetes in children treated with cyclosporine. N Engl J Med. 1988; 318: 663–670
   PubMed Web of Science ®Google Scholar
• Harrison L C, Colman P G, Dean B, Baxter R, Martin F I R. Increase in remission rate in newly diagnosed type 1 diabetic subjects treated with azathioprine. Diabetes. 1985; 34: 1306–1308
   PubMed Web of Science ®Google Scholar
• Silverstein J, Maclaren N, Riley W, Spillar R, Radjenovic D, Johnson S. Immunosuppression with azathioprine and prednisone in recent‐onset insulin‐dependent diabetes mellitus. N Engl J Med. 1988; 319: 599–604
   PubMed Web of Science ®Google Scholar
• Sutherland D E, Sibley R, Xu X Z, Michael A, Srikanta A M, Taub F, et al. Twin‐to‐twin pancreas transplantation: reversal and reenactment of the pathogenesis of type I diabetes. Trans Assoc Am Physicians. 1984; 97: 80–87
   PubMedGoogle Scholar
• Campbell I L, Harrison L C. Viruses and cytokines: Evidence for multiple roles in pancreatic beta cell destruction in type I insulin‐dependent diabetes mellitus. Journal of Cellular Biochemistry. 1989; 40: 57–66
   PubMedGoogle Scholar
• Leslie R D G, Pyke D A. Identical twins in diabetes. Immunology of diabetes, W J Irvine. Tevoit Scientific Publications, Edinburgh 1980; 101–108
   Google Scholar
• Maugh T H. Diabetes: epidemiology suggests a viral connection. Science 1975; 188: 347–351
   PubMed Web of Science ®Google Scholar
• Menser M A, Forrest J M, Bransby R D. Rubella infection and diabetes mellitus. Lancet. 1978; 1: 57–60
   PubMed Web of Science ®Google Scholar
• Yoon J ‐W, Austin M, Onodera T, Notkins A L. Virus‐ induced diabetes mellitus. Isolation of a virus from the pancreas of a child with diabetic ketoacidosis. N Engl J Med. 1979; 300: 1173–1179
   PubMed Web of Science ®Google Scholar
• Mordes J P, Desemone J, Rossini A A. The BB rat. Diabetes/Metab Rev. 1987; 3: 725–750
   PubMed Web of Science ®Google Scholar
• Parfrey N A, Prud'homme G J, Colle E, Fuks A, Seemayer T A, Guttmann R d. Immunologic and genetic studies of diabetes in the BB rat. CRC Crit Rev Immunol. 1989; 9: 45–65
   Google Scholar
• Lampeter E F, Signore A, Gale E A M, Pozzilli P. Lessons from the NOD mouse for the pathogenesis and immunotherapy of human Type 1 (insulin‐dependent) diabetes mellitus. Diubetologia. 1989; 32: 703–708
   PubMed Web of Science ®Google Scholar
• Chappel C I, Chappel W R. The discovery and development of the BB rat colony: An animal model of spontaneous diabetes mellitus. Metabolism. 1983; 32(Suppl. 1)8–10
   PubMedGoogle Scholar
• Butler L, Guberski D L, Like A A. Genetics of diabetes production in the Worcester colony of the BB rat. Frontiers in diabetes research: Lessons from unimal diabetes II, E Shafrir, A E Renold. John Libbey, London 1988; 74–78
   Google Scholar
• Sternthal E, Like A A, Sarantis K, Braverman L E. Lymphocytic thyroiditis and diabetes in the BB/W rat. Diabetes. 1981; 30: 1058–1061
   PubMed Web of Science ®Google Scholar
• Voorby H A M, Van der Gaag R D, Jeucken P H M, Bloot A M, Drexhage H A. The goitre of the BB/O rat: An animal‐model for studying the role of immunoglobulins stimulating growth of thyroid cells. Clin Exper Immunol. 1989; 76: 290–295
   PubMedGoogle Scholar
• Poussier P, Nakhooda A F, Falk J F, Lee C, Marliss E B. Lymphopenia and abnormal lymphocyte subsets in the “BB” rat: Relationship to the diabetic syndrome. Endocrinology. 1982; 110: 1825–1827
   PubMedGoogle Scholar
• Elder M E, Maclaren N K. Identification of profound peripheral T lymphocyte immunodeficiencies in the spon taneously diabetic BB rat. J Immunol. 1983; 130: 1723–1731
   PubMed Web of Science ®Google Scholar
• Guttmann R D, Colle E, Michel F, Seemayer T. Spontaneous diabetes mellitus in the rat. I. I. T lymphopenia and its associa tion with clinical disease and pancreatic lymphocytic infiltra tion. J Immunol. 1983; 130: 1732–1735
   PubMed Web of Science ®Google Scholar
• Jackson R, Rassi N, Crump T, Haynes B, Eisenbarth G S. The BB diabetic rat: profound T‐cell lymphocytopenia. Dinbetes. 1981; 30: 887–889
   PubMed Web of Science ®Google Scholar
• Woda B A, Padden C. BioBreeding/Worcester (BB/Wor) rats are deficient in the generation of functional cytotoxic T cells. J Immunol. 1987; 139: 1514–1517
   PubMed Web of Science ®Google Scholar
• Like A A, Guberski D L, Butler L. Diabetic BioBreeding/ Worcester (BB/Wor) rats need not be lymphopenic. J Immunol. 1986; 136: 3254–3258
   PubMedGoogle Scholar
• Makino S, Kunimoto K, Munaoko Y, Mizushima Y, Katagiri K, Tochino Y. Breeding of a non‐obese diabetic strain of mice. Exp Anim. 1980; 29: 1–13
   PubMedGoogle Scholar
• Leiter E H, Serreze D V, Prochazaka M. The genetics and epidemiology of diabetes in NOD mice. Imrnunol Today. 1990; 11: 147–149
   PubMedGoogle Scholar
• Kolb H. Mouse models of insulin dependent diabetes: Low‐ dose streptozotocin induced‐diabetes and nonobese diabetic (NOD) mice. Diaberesl Merab Rev. 1987; 3: 751–778
   Google Scholar
• Sarvetnick N, Liggitt D, Pitts S L, Hansen S E, Stewart T A. Insulin‐dependent diabetes mellitus induced in transgenic mice by ectopic expression of class II MHC and interferon‐ gamma. Cell. 1988; 52: 773–782
   PubMed Web of Science ®Google Scholar
• Böhme J, Haskins K, Stecha P, van Ewijk W, LeMeur M, Gerlinger P, et al. Transgenic mice with I‐A on islet cells are normoglycemic but immunologically tolerant. Science 1989; 244: 1179–1183
   PubMed Web of Science ®Google Scholar
• Lo D, Burkly L C, Widera G, Cowing C, Flavell R A, Palmiter R D, et al. Diabetes and tolerance in transgenic mice expressing class II MHC molecules in pancreatic beta cells. Cell. 1988; 53: 159–168
   PubMed Web of Science ®Google Scholar
• Allison J, Campbell I L, Morahan G, Mandel T E, Harrison L C, Miller J F A P. Diabetes in transgenic mice resulting from over‐expression of class I histocompatibility molecules in pancreatic beta cells. Nature 1988; 333: 529–533
   PubMed Web of Science ®Google Scholar
• Weringer E J, Like A A. Identification of T cell subsets and class I and class II antigen expression in islet grafts and pancreatic islets of diabetic BioBreeding/Worcester rats. Am J Pathol. 1988; 132: 292–303
   PubMed Web of Science ®Google Scholar
• Hanenberg H, Kolb‐Bachofen V, Kantwerk Funke G, Kolb H. Macrophage infiltration precedes and is a prerequisite for lymphocytic insulitis in pancreatic islets of pre‐diabetic BB rats. Diobetologia. 1989; 32: 126–134
   PubMed Web of Science ®Google Scholar
• Signore A, Pozzilli P, Gale E A, Andreani D, Beverley P C. The natural history of lymphocyte subsets infiltrating the pancreas of NOD mice. Diahetolngia. 1989; 32: 282–289
   Google Scholar
• Koevary S, Rossini A A, Stoller W, Chick W, Williams R M. Passive transfer of diabetes in the BB/W rat. Science 1983; 220: 727–728
   PubMed Web of Science ®Google Scholar
• Koevary S B, Williams D E, Williams R M, Chick W L. Passive transfer of diabetes from BB/W to Wistar‐Furth rats. J Clin Invest. 1985; 75: 1904–1907
   PubMedGoogle Scholar
• Gottlieb P A, Rossini A A, Mordes J P. Approaches to prevention and treatment of IDDM in animal models. Diab Cure. 1988; 11(Suppl. 1)29–36
   PubMedGoogle Scholar
• Like A A, Kislauskis E, Williams R M, Rossini A A. Neonatal thymectomy prevents spontaneous diabetes mellitus in the BB/W rat. Science 1982; 216: 644–646
   PubMed Web of Science ®Google Scholar
• Like A A, Biron C A, Weringer E J, Byman K, Sroczynski E, Guberski D L. Prevention of diabetes in BioBreeding/ Worcester rats with monoclonal antibodies that recognize T lymphocytes or natural killer cells. J Exp Med. 1986; 164: 1145–1159
   PubMed Web of Science ®Google Scholar
• Oschilewski U, Kiesel U, Kolb H. Administration of silica prevents diabetes in BB‐rats. Diabetes. 1985; 34: 197–199
   PubMed Web of Science ®Google Scholar
• Lefkowith J, Schreiner G, Cormier J, Handler E S, Driscoll H K, Greiner D, et al. Prevention of diabetes in the BB tat by essential fatty acid deficiency. Relationship between phy siological and biochemical changes. J Exp Med. 1990; 171: 729–743
   PubMedGoogle Scholar
• Kiesel U, Oschilewski M, Kantwerk G, Maruta M, Hanenberg H, Treichel U, et al. Essential role of macro‐ phages in the development of Type I diabetes in BB rats. Transplatit Proc. 1986; 18: 1525–1527
   Web of Science ®Google Scholar
• Walker R, Bone A J, Cooke A, Baird J D. Distinct macrophage subpopulations in pancreas of prediabetic BB/E rats. Possible role for macrophages in pathogenesis of IDDM. Diabetes. 1988; 37: 1301–1304
   PubMed Web of Science ®Google Scholar
• Lee K U, Kim M K, Amano K, Pak C Y, Jaworski M A, Mehta J G, et al. Preferential infiltration of macrophages during early stages of insulitis in diabetes‐prone BB rats. Diabetes. 1988; 37: 1053–1058
   PubMed Web of Science ®Google Scholar
• Voorbij H A M, Jeucken P H M, Kabel P J, de Haan M, Drexhage H A. Dendritic cells and scavenger macrophages in pancreatic islets of prediabetic BB rats. Diabetes. 1989; 38: 1623–1629
   PubMed Web of Science ®Google Scholar
• Prowse S J, Bellgrau D, Lafferty K J. Islet allografts are destroyed by disease occurrence in the spontaneously diabetic BB rat. Diabetes. 1986; 35: 110–114
   PubMed Web of Science ®Google Scholar
• Kurner T, Burkart V, Kolb H. Large increase of cytotoxic/ suppressor T‐lymphoblasts and eosinophils around manifes tation of diabetes in BB rats. Diabetes Res. 1986; 3: 349–353
   PubMedGoogle Scholar
• Nakhooda A F, Like A A, Chappel C I, Murray F T, Marliss E B. The spontaneously diabetic Wistar rat. Metabolic and morphologic studies. Diobetes. 1977; 26: 100–112
   PubMed Web of Science ®Google Scholar
• Gotfredsen C F, Buschard K, Frandsen E K. Reduction of diabetes incidence of BB Wistar rats by early prophylactic insulin treatment of diabetes‐prone animals. Diabetologia. 1985; 28: 933–935
   PubMed Web of Science ®Google Scholar
• Baekkeskov S, Dyrberg T, Lernmark Å. Autoantibodies to a 64‐kilodalton islet cell protein precede the onset of spontaneous diabetes in the BB rat. Science 1984; 224: 1348–1350
   PubMed Web of Science ®Google Scholar
• Atkinson M A, Maclaren N K. Autoantibodies in nonobese diabetic mice immunoprecipitate 64, 000‐Mr islet antigen. Diabetes. 1988; 37: 1587–1590
   PubMedGoogle Scholar
• Dotta F, Colman P G, Lombardi D, Scharp D W, Andreani D, Pontieri G M, et al. Ganglioside expression in human pancreatic islets. Diabetes. 1989; 38: 1478–1483
   PubMed Web of Science ®Google Scholar
• Dean B M, McNally J M, Bonifacio E, Jennings A M, Dunger D B, Gale E A M, et al. Comparison of insulin autoantibodies in diabetes‐related and healthy populations by precise displacement ELISA. Diabetes. 1989; 38: 1275–1281
   PubMed Web of Science ®Google Scholar
• Kämpe O, Anderson A, Björk E, Hallberg A, Karlsson F A. High‐glucose stimulation of 64, 000‐M, islet cell autoantigen expression. Diabetes. 1989; 38: 1326–1328
   PubMed Web of Science ®Google Scholar
• Weringer E J, Like A A. Immune attack on pancreatic islet transplants in the spontaneously diabetic BioBreeding/Worcester (BB/W) rat is not MHC restricted. J Immunol. 1985; 134: 2383–2386
   PubMed Web of Science ®Google Scholar
• Rossini A A, Williams R M, Mordes J P, Appel M C, Like A A. Spontaneous diabetes in the gnotobiotic BB/W rat. Diabetes. 1979; 28: 1031–1032
   PubMedGoogle Scholar
• Prochazka M, Leiter E H, Serreze D V, Coleman D L. Three recessive loci required for insulin‐dependent diabetes in nonobese diabetic mice. Science Nov 11, 1988; 242(4880)9451, ‘published erratum appears in Science 1987, 237, 286–289
   Google Scholar
• Wicker L S, Miller B J. MHC‐linked diabetogenic gene in the NOD mouse is not absolutely recessive. Annals of the New York Academy of Sciences 1988; 546: 240–241
   Google Scholar
• Hattori M, Buse J B, Jackson R A, Glimcher L, Dorf M E, Minami M, et al. The NOD mouse: Recessive diabetogenic gene in the major histocompatibilty complex. Science 1986; 231: 733–735
   PubMed Web of Science ®Google Scholar
• Nishimoto H, Kikutani H, Yamamura K, Kishimoto T. Prevention of autoimmune insulitis by expression of I‐E molecules in NOD mice. Nature 1987; 328: 432–434
   PubMed Web of Science ®Google Scholar
• Acha Orbea H, McDevitt H O. The first external domain of the nonobese diabetic mouse class II I‐A beta chain is unique. Proc Natl Acad Sei (USA). 1987; 84: 2435–2439
   PubMedGoogle Scholar
• Boitard C, Bendelac A, Richard M F, Carnaud C, Bach J F. Prevention of diabetes in nonobese diabetic mice by anti‐I‐A monoclonal antibodies: transfer of protection by splenic T cells. Proc Natl Acad Sci (USA). 1988; 85: 9719–9723
   PubMedGoogle Scholar
• Jackson R A, Buse J B, Rifai R, Pelletier D, Milford E L, Carpenter C B, et al. Two genes required for diabetes in BB rats. Evidence from cyclical intercrosses and backcrosses. J Exp Med. 1984; 159: 1629–1636
   PubMedGoogle Scholar
• Brayman K L, Markmann J F, Barker C F, Maji A. Immuno‐ prediction of diabetes and evaluation of pancreatic islet transplantation during the prediabetic period. Surgery. 1988; 104: 445–452
   PubMedGoogle Scholar
• Guberski D L, Butler K, Kastern W, Like A A. Genetic studies in inbred BB/Wor rats: Analysis of progeny produced by crossing lymphopenic diabetes‐prone rats with nonlym‐phopenic diabetic rats. Diabetes. 1989; 38: 887–893
   PubMed Web of Science ®Google Scholar
• Woda B A, Like A A, Padden C, McFadden M. Deficiency of phenotypic cytotoxic‐suppressor T lymphocytes in the BB/W rat. J Immunol. 1986; 136: 856–859
   PubMed Web of Science ®Google Scholar
• Bellgrau D, Lagarde A C. Cytotoxic T‐cell precursors with low‐level CD8 in the diabetes‐prone Biobreeding rat: impli cations for generation of autoimmune T‐cell repertoire. Proc Natl Acad Sci (USA). 1990; 87: 313–317
   PubMed Web of Science ®Google Scholar
• Greiner D L, Handler E S, Nakano K, Mordes J P, Rossini A A. Absence of the RT‐6 T cell subset in diabetes‐prone BB/W rats. J Immunol. 1986; 136: 148–151
   PubMed Web of Science ®Google Scholar
• MacKay P, Jacobson J, Rabinovitch A. Spontaneous diabetes mellitus in the BioBreeding/Worcester rat. Evidence in vitro for natural killer cell lysis of islet cells. J Clin Invest. 1986; 77: 916–924
   PubMedGoogle Scholar
• Woda B A, Biron C A. Natural killer cell number and function in the spontaneously diabetic BB/W rat. J Immunol. 1986; 137: 1860–1866
   PubMedGoogle Scholar
• Nakamura N, Woda B A, Tafuri A, Greiner D L, Reynolds C W, Ortaldo J, et al. Natural killer cells are intrinsically cytotoxic to pancreatic islets. in vitro. Diabetes. 1990; 39: 836–842
   PubMed Web of Science ®Google Scholar
• Lang F, Kastern W. The gene for the T lymphocyte alloan‐ tigen, RT6, is not linked to either diabetes or lymphopenia and is not defective in the BB rat. Eur J Immunol. 1989; 19: 1785–1789
   PubMedGoogle Scholar
• Gill T J I I I, Kunz H W, Misra D N, Cortese Hassett A L. The major histocompatibility complex of the rat. Transplantation. 1987; 43: 733–785
   Google Scholar
• Colle E, Guttmann R D, Seemayer T A. Spontaneous diabetes mellitus in the rat. I. Association with the major histocom patibility complex. J Exp Med. 1981; 154: 1237–1242
   PubMedGoogle Scholar
• Colle E, Guttmann R D, Fuks A. Insulin‐dependent diabetes mellitus is associated with genes that map to the right of the class 1 RT1. A locus of the major histocompatibility complex of the rat. Diabetes. 1986; 35: 454–458
   PubMedGoogle Scholar
• Boitard C, Michie S, Serrurier P, Butcher G W, Larkins A P, McDevitt H O. In vivo prevention of thyroid and pancreatic autoimmunity in the BB rat by antibody to class II major histocompatibility complex gene products. Proc Natl Acad Sci (USA). 1985; 82: 6627–6631
   PubMed Web of Science ®Google Scholar
• Ono S J, Colle E, Guttmann R D, Fuks A. MHC association of IDDM maps to permissive immune response genes. The immunology of autoimmune diabetes mellitus, M A Jaworski, G D Molnar, R V Rajotte, B Singh. Elsevier, Amsterdam 1986; 51–57
   Google Scholar
• Colle E, Guttmann R D, Seemayer T A, Michel F. Spontaneous diabetes mellitus syndrome in the rat. I. V. Immunogenetic interactions of MHC and non‐MHC components of the syndrome. Metabolism. 1983; 32(Suppl. 1)54–61
   PubMedGoogle Scholar
• Chao N J, Timmerman L, McDevitt H O, Jacob C O. Molecular characterization of MHC class 11 antigens (beta 1 domain) in the BB diabetes‐prone and ‐resistant rat. Immunogenetics. 1989; 29: 231–234
   PubMedGoogle Scholar
• Pollard D R, Gupta K, Mancino L, Hynie I. An immunofluorescence study of antipancreatic islet cell antibodies in the spontaneously diabetic BB Wistar rat. Diabetologia. 1983; 25: 56–59
   PubMedGoogle Scholar
• Dyrberg T, Nakhooda A F, Baekkeskov S, Lernmark Å, Poussier P, Marliss E B. Islet cell surface antibodies and lymphocyte antibodies in the spontaneously diabetic BB Wistar rat. Diabetes. 1982; 31: 278–281
   PubMed Web of Science ®Google Scholar
• Dyrberg T, Poussier P, Nakhooda A F, Marliss E B, Lernmark Å. Humordl immunity in the spontaneously diabetic BB rat. Metabolism. 1983; 32(Suppl. I)87–91
   PubMedGoogle Scholar
• Martin D R, Logothetopoulos J. Complement‐fixing islet cell antibodies in the spontaneously diabetic BB rat. Diabetes. 1984; 33: 93–96
   PubMed Web of Science ®Google Scholar
• Dyrberg T, Poussier P, Nakhooda A F, Baekkeskov S, Marliss E B, Lernmark A. Islet cell surface and lymphocyte antibodies often precede the spontaneous diabetes in the BB rat. Diabetologia. 1984; 26: 159–165
   PubMed Web of Science ®Google Scholar
• Elder M, Maclaren N, Riley W, McConnell T. Gastric parietal cell and other autoantibodies in the BB rat. Diabetes. 1982; 31: 313–318
   PubMed Web of Science ®Google Scholar
• Like A A, Appel M C, Rossini A A. Autoantibodies in the BB/W rat. Diabetes. 1982; 31: 816–820
   PubMed Web of Science ®Google Scholar
• Allen E M, Appel M C, Braverman L E. The effect of iodide ingestion on the development of spontaneous lymphocytic thyroiditis in the diabetes‐prone BB/W rat. Endocrinology. 1986; 118: 1977–1981
   PubMed Web of Science ®Google Scholar
• Reinhardt W, Appel M C, Alex S, Yang Y N, Braverman L E. The inhibitory effect of large doses of methimazole on iodine induced lymphocytic thyroiditis and serum anti‐thyrog‐ lobulin antibody titers in BB/Wor rats. Journal of Endocrinological Investigation. 1989; 12: 559–563
   PubMedGoogle Scholar
• Colle E, Guttmann R D, Seemayer T A. Association of spon taneous thyroiditis with the major histocompatibility complex of the rat. Endocrinology. 1985; 116: 1243–1247
   PubMedGoogle Scholar
• Rajatanavin R, Appel M C, Alex S, Yang Y, Reinhardt W, Braverman L E. Variable incidence of spontaneous and iodine induced lymphocytic thyroiditis in different lines of the BB/Wor rat. Endocrine Society, 71st Annual Meeting. Seattle, WA 1989; 477, (Abstract)
   Google Scholar
• Laupacis A, Stiller C R, Gardell C, Keown P, Dupré J, Wallace A C, et al. Cyclosporin prevents diabetes in BB Wistar rats. Lancet. 1983; 1: 10–12
   PubMed Web of Science ®Google Scholar
• Jaworski M A, Honore L, Jewell L D, Mehta J G, McGuire‐ Clark P, Schouls J J, et al. Cyclosporin prophylaxis induces long‐term prevention of diabetes, and inhibits lymphocytic infiltration in multiple target tissues in the high‐risk BB rat. Diabetes Res. 1986; 3: 1–6
   PubMedGoogle Scholar
• Like A A, Dirodi V, Thomas S, Guberski D L, Rossini A A. Prevention of diabetes mellitus in the BB/W rat with cyclosporin‐A. Am J Path. 1984; 117: 92–97
   PubMedGoogle Scholar
• Like A A, Anthony M, Guberski D L, Rossini A A. Spon taneous diabetes mellitus in the BB/W rat. Effects of gluco‐ corticoids, cyclosporin‐A, and antiserum to rat lymphocytes. Diabetes. 1983; 32: 326–330
   PubMedGoogle Scholar
• Like A A, Rossini A A, Guberski D L, Appel M C, Williams R M. Spontaneous diabetes mellitus: reversal and prevention in the BB/W rat with antiserum to rat lymphocytes. Science 1979; 206: 1421–1423
   PubMed Web of Science ®Google Scholar
• Rossini A A, Slavin S, Woda B A, Geisberg M, Like A A, Mordes J P. Total lymphoid irradition prevents diabetes mellitus in the Bio‐BreedinglWorcester (BB/W) rat. Diabetes. 1984; 33: 543–547
   PubMed Web of Science ®Google Scholar
• Haskins K, Portas M, Bradley B, Wegmann D, Lafferty K. T‐lymphocyte clone specific for pancreatic islet antigen. Diabetes. 1988; 37: 1444–1448
   PubMed Web of Science ®Google Scholar
• Reich E ‐P, Scaringe D, Yagi J, Sherwin R S, Janeway C A, Jr. Prevention of diabetes in NOD mice by injection of auto‐reactive T‐lymphocytes. Diabetes. 1989; 38: 1647–1651
   PubMedGoogle Scholar
• Nerup J, Mandrup Poulsen T, Mslvig J, Helqvist S, Wogensen L, Egeberg J. Mechanisms of pancreatic β‐cell destruction in type I diabetes. Diab Care. 1988; 11(Suppl. I)16–23
   PubMedGoogle Scholar
• Bendtzen K, Mandrup‐Poulsen T, Nerup J, Nielsen J H, Dinarello C A, Svenson M. Cytotoxicity of human p17 interleukin‐1 for pancreatic islets of Langerhans. Science 1986; 232: 1545–1547
   PubMed Web of Science ®Google Scholar
• Palmer J P, Helqvist S, Spinas G A, Mslvig J, Mandrup‐Poul sen R, Andersen H U, et al. Interaction of β‐cell activity and IL‐I concentration and exposure time in isolated rat islets of Langcrhans. Diabetes. 1989; 38: 1211–1216
   PubMed Web of Science ®Google Scholar
• Pukel C, Baquerizo H, Rabinovitch A. Destruction of rat islet cell monolayers by cytokines. Synergistic interactions of interferon‐gamma, tumor necrosis factor, lymphotoxin. and interleukin 1. Diabetes. 1988; 37: 133–136
   PubMed Web of Science ®Google Scholar
• Kitagawa Y, Tafuri A, Greiner D L, Reynolds C, Ortaldo J, Rossini A A. Cytolysin (perforin) and natural killer cell cytotoxic factor are cytotoxic to islet cells but not thyrocytes. Diabetes. 1990; 39(Suppl. 1)97A, (Abstract)
   Google Scholar
• Mordes J P, Rossini A A. Keys to understanding autoimmune diabetes mellitus: The animal models of insulin‐dependent diabetes mellitus. Ballière's Clin Immunol Allergy 1987; 1: 29–52
   Google Scholar
• Karam J H, Lewitt P A, Young C W, Nowlain R E, Frankel B J, Fujiya H, et al. Insulinopenic diabetes after rodenticide (Vacor) ingestion: A unique model of acquired diabetes in man. Diabetes. 1980; 29: 971–978
   PubMed Web of Science ®Google Scholar
• Nomikos I N, Prowse S J, Carotenuto P, Lafferty K J. Combined treatment with nicotinamide and desferrioxamine prevents islet allograft destruction in NOD mice. Diabetes. 1986; 35: 1302–1304
   PubMed Web of Science ®Google Scholar
• Logothetopoulos J, Valiquette N, Madura E, Cvet D. The onset and progression of pancreatic insulitis in the overt, spontaneously diabetic, young adult BB rat studied by pancreatic biopsy. Diabetes. 1984; 33: 33–36
   PubMed Web of Science ®Google Scholar
• Seemayer T A, Colle E, Tannenbaum G S, Oligny L L, Guttmann R D, Goldman H. Spontaneous diabetes mellitus syndrome in the rat. III. Pancreatic alterations in aglycosuric and untreated diabetic BB Wistar‐derived rats. Metabolism. 1983; 32(Suppl. 1)26–32
   PubMedGoogle Scholar
• Erb P, Grogg D, Troxler M, Kennedy M, Fluri M. CD4+ T cell‐mediated killing of MHC class II–positive antigen‐ presenting cells. I. characterization of target cell recognition by in vivo or in vitro activated CD4+ killer T cells. J. Immunol. 1990; 144: 790–795
   PubMedGoogle Scholar
• Dean B M, Walker R, Bone A J, Baird J D, Cooke A. Pre‐ diabetes in the spontaneously diabetic BB/E rat: lymphocyte subpopulations in the pancreatic infiltrate and expression of rat MHC class II molecules in endocrine cells. Diabetologia. 1985; 28: 464–466
   PubMed Web of Science ®Google Scholar
• Voorby H A M, Kabel P J, de Haan M, Jeucken P H M, Van der Gaag R D, De Baets M H, et al. Dendritic cells and class II MHC expression on thyrocytes during the autoimmune thyroid disease of the BB rat. Clin Immunol Imrnunopathol. 1990; 55: 9–22
   PubMedGoogle Scholar
• Int Veld P A, Pipeleers D G. In situ analysis of pancreatic islets in rats developing diabetes. Appearance of non‐ endocrine cells with surface MHC class II antigens and cyto‐ plasmic insulin immunoreactivity. J Clin Invest. 1988; 82: 1123–1128
   PubMedGoogle Scholar
• Timsit J, Savino W, Boitard C, Bach J F. The role of class 11 major histocompatibility complex antigens in autoimmune diabetes: animal models. J Autoimmun. 1989; 2: 115–129
   PubMedGoogle Scholar
• Markmann J F, Hickey W F, Kimura H, Woehrle M, Barker C F, Naji A. Gamma interferon induces novel expression of Ia antigens by rat pancreatic islet endocrine cells. Pancreas. 1987; 2: 258–261
   PubMedGoogle Scholar
• Hanafusa T, Fujino Kurihara H, Miyazaki A, Yamada K, Nakajima H, Miyagawa J, et al. Expression of class II histo‐ compatibility complex antigens on pancreatic B cells in the NOD mouse. Diabetologia. 1987; 30: 104–108
   PubMedGoogle Scholar
• Formby B, Miller N. Autologous CD4 T‐cell responses to ectopic class II major histocompatibility complex antigen‐ expressing single‐cell islet cells: an in vitro insight into the pathogenesis of lymphocytic insulitis in nonobese diabetic mice. Proc Natl Acad Sci (USA). 1990; 87: 2438–2442
   PubMedGoogle Scholar
• Murphy K M, Weaver C T, Elish M, Allen P M, Loh D Y. Peripheral tolerance to allogeneic class II histocompatibility antigens expressed in transgenic mice: evidence against a clonal‐deletion mechanism. Proc Natl Acad Sci (USA). 1989; 86: 10034–10038
   PubMedGoogle Scholar
• Harrison L C, Campbell I L, Allison J, Miller J F A P. MHC molecules and β‐cell destruction: Immune and nonimmune mechanisms. Diabetes. 1989; 38: 815–818
   PubMedGoogle Scholar
• Markmann J, Lo D, Maji A, Palmiter R D, Brinster R L, Heber Katz E. Antigen presenting function of class II MHC expressing pancreatic beta cells. Nature 1988; 336: 476–479
   PubMed Web of Science ®Google Scholar
• Wicker L S, Miller B J, Mullen Y. Transfer of autoimmune diabetes mellitus with splenocytes from nonobese diabetic (NOD) mice. Diabetes. 1986; 35: 855–860
   PubMed Web of Science ®Google Scholar
• Bendelac A, Carnaud C, Boitard C, Bach J F. Syngeneic transfer of autoimmune diabetes from diabetic NOD mice to healthy neonates. Requirement for both L3T4+ and Lyt‐2 + T cells. J Exp Med. 1987; 166: 823–832
   PubMed Web of Science ®Google Scholar
• Hanafusa T, Sugihara S, Fujino Kurihara H, Miydgdwa J, Miyazaki A, Yoshioka T, et al. Induction of insulitis by adoptive transfer with L3T4 + Lyt2‐T‐lymphocytes in T‐ lymphocyte‐depleted NOD mice. Diabetes. 1988; 37: 204–208
   PubMed Web of Science ®Google Scholar
• Miller B J, Appel M C, O'Neil J J, Wicker L S. Both the Lyt‐ 2+ and L3T4+ Tcell subsets are required for the transfer of diabetes in nonobese diabetic mice. J Immunol. 1988; 140: 52–58
   PubMed Web of Science ®Google Scholar
• Bendelac A, Boitard C, Bedossa P, Bazin H, Bach J ‐F, Carnaud C. Adoptive T cell transfer of autoimmune nonobese diabetic mouse diabetes does not require recruit ment of host B lymphocytes. Journal of Immunology. 1988; 141: 2625–2628
   PubMed Web of Science ®Google Scholar
• LaFace D M, Peck A B. Reciprocal allogeneic bone marrow transplantation between NOD mice and diabetes‐nonsus‐ ceptible mice associated with transfer and prevention of autoimmune diabetes. Diabetes. 1989; 38: 894–901
   PubMed Web of Science ®Google Scholar
• Handler E S, Mordes J P, McKeever U, Nakamura N, Bernhard J, Greiner D I, et al. Effects of irradiation on diabetes in the BB/Wor rat. Autoimmunity. 1989; 4: 21–30
   PubMed Web of Science ®Google Scholar
• McKeever U, Mordes J P, Greiner D L, Appel M C, Rozing J, Handler E S, et al. Adoptive transfer of autoimmune diabetes and thyroiditis to athymic rats. Proc Natl Acad Sci (USA). 1990, (In press)
   Google Scholar
• Hodes R J, Sharrow S O, Solomon A. Failure of T cell receptor Vβ negative selection in an athymic environment. Science 1989; 246: 1041–1044
   PubMedGoogle Scholar
• Fry A, Jones L A, Kruisbeek A M, Matis L A. Thymic require ment for clonal deletion during T cell development. Science 1989; 246: 1044–1046
   PubMed Web of Science ®Google Scholar
• Speiser D E, Lees R K, Hengartner H, Zinkernagel R M, MacDonald H R. Positive and negative selection of T cell receptor Vβ domains controlled by distinct cell populations in the thymus. J Exp Med. 1989; 170: 2165–2170
   PubMedGoogle Scholar
• Reich E ‐P, Sherwin R S, Kanagawa O, Janeway C A, Jr. An explanation for the protective effect of the MHC class II I‐E molecule in murine diabetes. Nature 1989; 341: 326–328
   PubMed Web of Science ®Google Scholar
• Kappler J W, Roehm N, Marrack P. T cell tolerance by clonal elimination in the thymus. Cell. 1987; 49: 273–280
   PubMed Web of Science ®Google Scholar
• Scott J, Engelhard V H, Benjamin D C. Bone marrow irradiation chimeras in the BB rat: Evidence suggesting two defects leading to diabetes and lymphopenia. Diabetologia. 1987; 30: 774–781
   PubMedGoogle Scholar
• Rozing J, Coolen C, Tielen F J, Weegenaar J, Schuurman H ‐J, Greiner D L, et al. Defects in the thymic epithelial stroma of diabetes prone BB rats. Thymus. 1989; 140: 125–135
   Google Scholar
• Georgiou H M, Lagarde A C, Bellgrau D. T cell dysfunction in the diabetes‐prone BB rat. A role for thymic migrants that are not T cell precursors. J Exp Med. 1988; 167: 132–148
   PubMed Web of Science ®Google Scholar
• Georgiou H M, Bellgrau D. Thymus transplantation and disease prevention in the diabetes‐prone Bio‐Breeding rat. J Immunol. 1989; 142: 3400–3405
   PubMed Web of Science ®Google Scholar
• Sakaguchi S, Fukuma K, Kuribyashi K, Masuda T. Organspecific autoimmune diseases induced in mice by elimination of T cell subset. I. Evidence for the active participation of T cells in natural self‐tolerance: Deficit of a T cell subset as a possible cause of autoimmune disease. J Exp Med. 1985; 161: 72–87
   PubMed Web of Science ®Google Scholar
• Sakaguchi S, Sakaguchi N. Thymus and autoimmunity. Transplantation of the thymus from cyclosporin A‐treated mice causes organ‐specific autoimmune disease in athymic nude mice. J Exp Med. 1988; 167: 1479–1485
   PubMed Web of Science ®Google Scholar
• Yale J ‐F, Grose M, Marliss E B. Time course of the lymphopenia in BB rats. Relation to the onset of diabetes. Diabetes. 1985; 34: 955–959
   PubMedGoogle Scholar
• Rossini A A, Mordes J P, Greiner D L, Nakano K, Appel M C, Handler E S. Spleen cell transfusion in the BB/W rat: Prevention of diabetes, MHC restriction, and long term per sistence of transfused cells. J Clin Invest. 1986; 77: 1399–1401
   PubMedGoogle Scholar
• Burstein D, Mordes J P, Greiner D L, Stein D, Nakamura N, Handler E S, et al. Prevention of diabetes in the BB/Wor rat by a single transfusion of spleen cells: Parameters that affect the degree of protection. Diabetes. 1989; 38: 24–30
   PubMed Web of Science ®Google Scholar
• Greiner D L, Mordes J P, Handler E S, Angelillo M, Nakamura N, Rossini A A. Depletion of RT6.1+ T lympho cytes induces diabetes in resistant BioBreeding/Worcester (BB/W) rats. J Exp Med. 1987; 166: 461–475
   PubMed Web of Science ®Google Scholar
• Angelillo M, Greiner D L, Mordes J P, Handler E S, Nakamura N, McKeever U, et al. Absence of RT6+ T cells in diabetes‐prone BioBreeding/Worcester rats is due to genetic and cell developmental defects. J Immund. 1988; 141: 4146–4151
   PubMedGoogle Scholar
• Thiele H ‐G, Koch F, Haag F, Wurst W. Evidence for normal thymic export of lymphocytes and an intact RT6a gene in RT6 deficient diabetes prone BB‐rats. Thymus. 1989; 14: 137–143
   PubMedGoogle Scholar
• Crisá L, Greiner D L, Mordes J P, MacDonald R G, Handler E S, Czech M P, et al. Biochemical studies of RT6 alloantigens in BB/Wor and normal rats: Evidence for an intact but unexpressed RT6a structural gene in the diabetes prone BB rat. Diabetes. 1990, In press
   PubMedGoogle Scholar
• Haag F, Koch F, Thiele H ‐G. Nucleotide and deduced amino acid sequence of the rat T‐cell alloantigen RT6.1. Nucleic Acids Res. 1990; 18: 1047–1047
   PubMedGoogle Scholar
• Koch F, Haag F, Kashan A, Thiele H ‐G. Primary structure of rat RT6.2, a non‐glycosylated phosphatidylinositol‐linked surface marker of postthymic T cells. Proc Natl Acad Sci (USA). 1990; 87: 964–967
   PubMedGoogle Scholar
• Klinkcrt W E, LaBadie J H, Bowers W E. Accessory and stimulating properties of dendritic cells and macrophages isolated from various rat tissues. J Exp Med. 1982; 156: 1–19
   PubMedGoogle Scholar
• Voorbij J A M. Dendritic cells and the development of thyroid uutoimmune disease and Type I diabetes mellitus. Thesis Publishers, Amsterdam 1989
   Google Scholar
• Harada M, Makino S. Suppression of overt diabetes in NOD mice by anti‐thymocyte serum or anti‐Thy 1.2 antibody. Exp Anim. 1986; 35: 501–504
   PubMed Web of Science ®Google Scholar
• Oschilewski M, Schwab E, Kiesel U, Opitz U, Stuenkel K, Kolb‐Bachofen V, et al. Administration of silica or monoclonal antibody to Thy‐I prevents low‐dose strepto‐ zotocin induced diabetes in mice. Immunol Lett. 1986; 12: 289–295
   PubMedGoogle Scholar
• Gottlieb P A, Berrios J P, Mariani G, Handler E S, Greiner D, Mordes J P, et al. Autoimmune destruction of islets trans planted into RT6‐depleted diabetes‐resistant BB/Wor rats. Diabetes. 1990; 39: 643–645
   PubMed Web of Science ®Google Scholar
• Winter W E, Maclaren N K, Riley W J, Clarke D W, Kappy M S, Spillar R P. Maturity‐onset diabetes of youth in black americans. N Engl J Med. 1987; 316: 285–291
   PubMed Web of Science ®Google Scholar
• Mordes J P, McKeever U, Handler E S, Greiner D L, Burstein D, Rossini A A. “Immune modulation” of autoimmune diabetes in the BB rat. Frontiers in diabetes research: Lessons from animal diabetes II, A E Renold, E Shafrir. John Libbey & Co., London 1988; 167–173
   Google Scholar